9312 Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs)
Grob, J., Hamid, O., Wolchok, J., Maio, M., Neyns, B., Thomas, L., de Pril, V., Ibrahim, R., O'Day, S., Lebbé, C.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71956-1
Date:
September, 2009
File:
PDF, 50 KB
english, 2009